Drospirenone, ethinyl estradiol, and levomefolate and Ibritumomab Tiuxetan
Determining the interaction of Drospirenone, ethinyl estradiol, and levomefolate and Ibritumomab Tiuxetan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: drospirenone / ethinyl estradiol / levomefolate calcium
Brand name: Beyaz, Safyral, Rajani, Tydemy
Synonyms: Ethinyl Estradiol, Drospirenone, and Levomefolate
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Drospirenone, ethinyl estradiol, and levomefolate-Ibrutinib
- Drospirenone, ethinyl estradiol, and levomefolate-Ibrutinib Capsules
- Drospirenone, ethinyl estradiol, and levomefolate-Ibrutinib Tablets
- Drospirenone, ethinyl estradiol, and levomefolate-Ibu
- Drospirenone, ethinyl estradiol, and levomefolate-IBU Tablets
- Drospirenone, ethinyl estradiol, and levomefolate-Ibu-2
- Ibritumomab Tiuxetan-DroTuss-CP
- Ibritumomab Tiuxetan-Droxia
- Ibritumomab Tiuxetan-Droxidopa
- Ibritumomab Tiuxetan-Dry Eye Omega Benefits
- Ibritumomab Tiuxetan-DryMax
- Ibritumomab Tiuxetan-DryMax Syrup